Haemonetics Corporation expanding Upstate operations
October 14, 2015
Company Investing Nearly $20 Million To Expand And Upgrade Union County Facility
UNION COUNTY, SC – Haemonetics, the global leader in blood management solutions, is expanding its existing operations in Union County. The company is investing nearly $20 million in the expansion, which is expected to create 40 new jobs over the next five years.
Established in 1971 and headquartered in Braintree, Mass., Haemonetics operates facilities on four continents across the globe, employing almost 4,000 workers worldwide. The company has a comprehensive portfolio of devices, information management and consulting services, serving each facet of the blood supply chain – from plasma and blood collectors to hospitals.
Haemonetics recently celebrated 20 years at its current Union County site, which is located at 155 Medical Sciences Drive in Union, S.C. In this latest investment, the company will be expanding the existing facility by 3,000 square-feet, as well as making significant upgrades to plant equipment and infrastructure.
Products manufactured at the Union County site are required for plasmapheresis, during which the raw material in life saving plasma therapies is collected. Therapies treat a variety of disease states including immune deficiencies, hemophilia, and other blood disorders.
Improvements to the facility and hiring for the 40 new positions is already underway. Those interested in joining the Haemonetics team should visit the company’s careers page online. For more information on Haemonetics Corporation, visit www.haemonetics.com.
The Coordinating Council for Economic Development has approved a $400,000 Rural Infrastructure Fund grant to Union County to assist with the cost of real property improvements. The Council has also approved job development credits related to the project.
“The South Carolina community has been an integral partner in our manufacturing operations for the last 20 years, and our decision to further invest in the Union facility reflects upon the diverse pool of talent, partners and resources that South Carolina has to offer. I look forward to continuing our strategy of continuous improvement and manufacturing excellence in Union, helping to further support our global product lines.” –Haemonetics Corporation CEO Ron Gelbman
“Haemonetics continues to be a great corporate partner for Union County and we are very excited about their additional investment in our community. We view this expansion as further confirmation that Union County continues to be a great place to do business in South Carolina. We are appreciative and proud to support their investment and job creation efforts now and in the future.” –Union County Supervisor and Chairman of County Council Frank Hart
“Haemonetics is a staple in Union County with more than 20 years at its current location. It has been my pleasure working with the Haemonetics management team, Department of Commerce, and our local officials on this investment of approximately $20 million for our community and 40 career opportunities for our citizens. Thank you, Haemonetics, for your continued commitment and support of Union County.” –Union County Development Board Chairman Joe Nichols
FIVE FAST FACTS
• Haemonetics Corporation is expanding its Union County operations.
• Nearly $20 million investment creating 40 new jobs.
• Established in 1971, Haemonetics Corporation is headquartered in Braintree, Mass.
• The company will be expanding the existing facility by 3,000 square-feet, as well as making significant upgrades to plant equipment and infrastructure.
• Those interested in joining the Haemonetics team should visit the company’s careers page online.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve patient care and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at www.haemonetics.com.
